The RNA sequencing analysis of 140 samples of the two cohorts ‘gliomas and BM revealed samples with gene rearrangements that involve NTRK3, FGFR3, ERG, EGFR, or MET genes in seven samples (5%) (Figure 4). The gene discussed is EGFR; the disease is central nervous system cancer.